Initially, Íbero Botanica will operate as a CBD hemp production facility, and in parallel transition to cultivating premium medicinal cannabis (THC), product for export.
Our experience and capabilities plus our strong relationships within the pharmaceutical industry allow us to adapt quickly to evolving regulations whilst continuing to drive growth, shareholder value and meet the increasing demand in Europe.